ARCHIVES

Drugs Available To Investigators Centers to Monitor Them Are Listed

This article is from The Cancer Letter archive.

Vol. 03 No. 36 | September 9, 1977

Download PDF Visit The Full Archive

Related Articles

NCI To Expand SPORE Grants Program to Increase Translational Research Funding

October 22, 1999

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel

June 1, 2001

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004

Survey supports removal of cancer care cuts from Medicare bills.

September 26, 2003

Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate

May 11, 1979